4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0000899243-16-033335
Director sold 86,270 shares at an average $11.16 ($962,907)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Canaan IX L.P. Director | 2016-11-10 | Sale | −27,135 | $11.07 | $300,390 | 3,903,516 | I: show line 1 in the form |
| Canaan IX L.P. Director | 2016-11-11 | Sale | −35,391 | $11.20 | $396,461 | 3,868,125 | I: show line 2 in the form |
| Canaan IX L.P. Director | 2016-11-14 | Sale | −23,744 | $11.21 | $266,056 | 3,844,381 | I: show line 3 in the form |
| Open-market sales · 86,270 sh · avg $11.16 · $962,907 | |||||||
Loading xslF345X03/doc4.xml…